Sleep breathing disorders in adolescents with asthma.

Eur Ann Allergy Clin Immunol

Allergy and Clinical Immunology Department, Hospital de Dona Estefânia, Unidade Local de Saúde (ULS) São José, Lisbon, Portugal.

Published: November 2024

AI Article Synopsis

  • Childhood asthma is linked to sleep-breathing disorders (SBD), but there is a lack of research specifically focusing on adolescents, prompting this study to investigate SBD frequency and risk factors in this age group.
  • The study involved 98 adolescents with asthma and found that 25.5% were at high risk for SBD, with significant associations between high SBD risk and factors like increased body mass index (BMI), uncontrolled rhinitis, and asthma.
  • Results indicate that higher BMI is a key predictor of SBD risk in this population, highlighting the need for targeted preventive strategies and interventions addressing modifiable factors related to asthma and SBD in adolescents.

Article Abstract

Childhood asthma, a chronic inflammatory disease, is linked to sleep-breathing disorders (SBD). The vulnerability of asthmatic children to SBDs is well-established, yet limited research focuses on adolescents. This study addresses the research gap, exploring the frequency and risk factors of SBD in adolescents with asthma. A cross-sectional study was conducted among 98 adolescents (12-17 years) with asthma at a Lisbon healthcare facility. Comprehensive assessments, including sociodemographic data, medical history, lung function variables, and validated questionnaires for SBD risk (Pediatric Sleep Questionnaire), rhinitis control, and asthma control (Control of Allergic Rhinitis and Asthma Test and Asthma Control Test), were employed. The study revealed a substantial frequency of SBD symptoms, with 25.5% of adolescents classified as high-risk based on the Pediatric Sleep Questionnaire. Significant associations were identified between high SBD risk and elevated body mass index (BMI), uncontrolled rhinitis, and uncontrolled asthma. Logistic regression analysis confirmed elevated BMI as a robust predictor of SBD risk, indicating a 5.9-fold increase compared to normal-weight counterparts. This study contributes valuable insights into the interplay between asthma and SBD in adolescents. The high prevalence of SBD symptoms, particularly among those with excess weight and uncontrolled respiratory symptoms, underscores the need for targeted preventive strategies. The identified risk factors, notably elevated BMI, provide clinicians with actionable information for intervention, emphasizing the importance of addressing modifiable factors associated with asthma and SBD in this specific population.

Download full-text PDF

Source
http://dx.doi.org/10.23822/EurAnnACI.1764-1489.377DOI Listing

Publication Analysis

Top Keywords

sbd risk
12
asthma
10
sbd
9
adolescents asthma
8
risk factors
8
sbd adolescents
8
pediatric sleep
8
sleep questionnaire
8
asthma control
8
sbd symptoms
8

Similar Publications

Development of a nano-specific safe-by-design module to identify risk management strategies.

Ann Work Expo Health

December 2024

TNO Research Group Risk Analysis for Prevention, Innovation and Development, Princetonlaan 6, PO Box 80015, Utrecht 3584 CB, The Netherlands.

This article describes the development of a Safe-by-Design (SbD) module and its integration into an easy-to-use tool, named the Nano Exposure Quantifier-Safe-by-Design (NEQ-SbD) tool. The NEQ-SbD tool guides its user to lower the exposure to nanomaterials at the worksite where nanomaterials are manipulated or handled during a wide range of activities. This allows the tool user with an informed decision to assess airborne exposure and to select, compare, and identify appropriate risk management measures (RMM).

View Article and Find Full Text PDF

It is not well investigated whether exposure to specific drug classes is associated with COVID-19. We investigated the risk of SARS-CoV-2 infection and severe COVID-19 among healthcare workers according to prescription drug use. We conducted an observational study among Danish healthcare workers.

View Article and Find Full Text PDF

Sleep breathing disorders in adolescents with asthma.

Eur Ann Allergy Clin Immunol

November 2024

Allergy and Clinical Immunology Department, Hospital de Dona Estefânia, Unidade Local de Saúde (ULS) São José, Lisbon, Portugal.

Article Synopsis
  • Childhood asthma is linked to sleep-breathing disorders (SBD), but there is a lack of research specifically focusing on adolescents, prompting this study to investigate SBD frequency and risk factors in this age group.
  • The study involved 98 adolescents with asthma and found that 25.5% were at high risk for SBD, with significant associations between high SBD risk and factors like increased body mass index (BMI), uncontrolled rhinitis, and asthma.
  • Results indicate that higher BMI is a key predictor of SBD risk in this population, highlighting the need for targeted preventive strategies and interventions addressing modifiable factors related to asthma and SBD in adolescents.
View Article and Find Full Text PDF
Article Synopsis
  • Respiratory syncytial virus (RSV) commonly causes severe respiratory infections, especially in infants and vulnerable populations, and predicting its clinical course can be challenging as many severe cases occur in healthy individuals.
  • Recent advancements in RSV vaccines and monoclonal antibodies make it crucial to identify high-risk people who would benefit from preventive treatments.
  • Research using animal models has revealed complex immune responses to RSV, suggesting that specific immune system components and genetic markers may help in predicting disease severity and identifying at-risk patients for future studies.
View Article and Find Full Text PDF
Article Synopsis
  • In 2023, the USA spent $99 billion on cancer therapies, with projections reaching $180 billion by 2028, primarily due to high launch prices and increasing costs of existing treatments.
  • The escalating prices hinder access and affordability for Americans, leading to higher risks of non-adherence to treatment, cancer recurrence, and mortality.
  • In response, governments have implemented policies to limit out-of-pocket costs, expand subsidies, and enable drug price negotiations, while also calling for further solutions to enhance affordability and value in cancer care.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!